Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

Lantheus Medical Imaging, JBCPL partner to launch DEFINITY ultrasound contrast imaging agent in India

Lantheus Medical Imaging, JBCPL partner to launch DEFINITY ultrasound contrast imaging agent in India

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

University of Michigan professor recognised with PHA Award of Excellence

University of Michigan professor recognised with PHA Award of Excellence

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

Lantheus Medical Imaging reports new Phase 4 data from DEFINITY study

Lantheus Medical Imaging reports new Phase 4 data from DEFINITY study

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Phase II study results of riociguat for CTEPH and PAH published online

Phase II study results of riociguat for CTEPH and PAH published online

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Gene therapy shows positive effects in rat models of PAH: Researchers

Gene therapy shows positive effects in rat models of PAH: Researchers

REVEAL risk score calculator provides innovative approach to better understand PAH

REVEAL risk score calculator provides innovative approach to better understand PAH

Anti-abortion groups use health law in efforts to restrict insurance coverage

Anti-abortion groups use health law in efforts to restrict insurance coverage

High-altitude exposure helps detect early vascular dysfunction

High-altitude exposure helps detect early vascular dysfunction

Special issue of Progress in Cardiovascular Diseases

Special issue of Progress in Cardiovascular Diseases

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Accredo Health Group selected as sole specialty pharmacy provider of Epoprostenol for Injection

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.